Back to Agenda
Topic 2 Session 9 continued: Audits and Inspections in Pharmacovigilance – Industry Perspective
Speaker(s)
Jonathan Rowell
Director Regulatory Compliance, Janssen Pharmaceutical Research & Development Quality & Compliance, United Kingdom
Audits and Inspections in Pharmacovigilance - Industry Perspective
Have an account?
